目次

1. Executive Summary
1.1.Regional Market Share
1.2. Business Trends
1.3.Allergy Eye Drop Market: COVID-19 Outbreak
1.4.Regional Trends
1.5. Segmentation Snapshot

2. Research Methodology
2.1. Research Objective
2.2.Research Approach
2.3.Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1. Paid Sources
2.5.2.Public Sources
2.6.Market Size Estimation and Data Triangulation

3. Market Characteristics
3.1. Market Definition
3.2.Allergy Eye Drop Market: COVID-19 Impact
3.3.Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data

4. Allergy Eye Drop Market - Industry Insights
4.1.Industry Segmentation
4.2. COVID-19 overview of world economy
4.3. Industry Ecosystem Channel Analysis
4.4. Innovation & Sustainability

5. Macroeconomic Indicators

6. Recent Developments
7.Market Dynamics
7.1. Introduction
7.2.Growth Drivers
7.3.Market Opportunities
7.4. Market Restraints
7.5.Market Trends

8. Risk Analysis

9. Market Analysis
9.1. Porter's Five Forces
9.2.PEST Analysis
9.2.1. Political
9.2.2.Economic
9.2.3.Social
9.2.4.Technological

10. Allergy Eye Drop Market
10.1.Overview
10.2. Historical Analysis (2018-2022)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11.Allergy Eye Drop Market Size & Forecast 2024A-2034F
11.1.Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1.By Drug Class
11.3.1.1. Vasoconstrictors
11.3.1.1.1. By Value (USD Million) 2024A-2034F
11.3.1.1.2.Market Share (%) 2024A-2034F
11.3.1.1.3.Y-o-Y Growth (%) 2024A-2034F
11.3.1.2.Antihistamines
11.3.1.2.1.By Value (USD Million) 2024A-2034F
11.3.1.2.2. Market Share (%) 2024A-2034F
11.3.1.2.3. Y-o-Y Growth (%) 2024A-2034F
11.3.1.3.Non-steroidal Anti-Inflammatory Drugs
11.3.1.3.1.By Value (USD Million) 2024A-2034F
11.3.1.3.2. Market Share (%) 2024A-2034F
11.3.1.3.3. Y-o-Y Growth (%) 2024A-2034F
11.3.1.4.Others
11.3.1.4.1.By Value (USD Million) 2024A-2034F
11.3.1.4.2. Market Share (%) 2024A-2034F
11.3.1.4.3. Y-o-Y Growth (%) 2024A-2034F
11.3.2. By Type
11.3.2.1.Vernal Keratoconjunctivitis
11.3.2.1.1.By Value (USD Million) 2024A-2034F
11.3.2.1.2. Market Share (%) 2024A-2034F
11.3.2.1.3. Y-o-Y Growth (%) 2024A-2034F
11.3.2.2. Seasonal and Perennial Allergic Conjunctivitis
11.3.2.2.1. By Value (USD Million) 2024A-2034F
11.3.2.2.2.Market Share (%) 2024A-2034F
11.3.2.2.3.Y-o-Y Growth (%) 2024A-2034F
11.3.2.3. Atopic Keratoconjunctivitis
11.3.2.3.1. By Value (USD Million) 2024A-2034F
11.3.2.3.2.Market Share (%) 2024A-2034F
11.3.2.3.3.Y-o-Y Growth (%) 2024A-2034F
11.3.2.4. Giant Papillary Conjunctivitis
11.3.2.4.1. By Value (USD Million) 2024A-2034F
11.3.2.4.2.Market Share (%) 2024A-2034F
11.3.2.4.3. Y-o-Y Growth (%) 2024A-2034F
11.3.2.5. Others
11.3.2.5.1. By Value (USD Million) 2024A-2034F
11.3.2.5.2.Market Share (%) 2024A-2034F
11.3.2.5.3.Y-o-Y Growth (%) 2024A-2034F
11.3.3. By Distribution Channel
11.3.3.1.Online Pharmacies
11.3.3.1.1.By Value (USD Million) 2024A-2034F
11.3.3.1.2. Market Share (%) 2024A-2034F
11.3.3.1.3. Y-o-Y Growth (%) 2024A-2034F
11.3.3.2. Retail Pharmacies
11.3.3.2.1. By Value (USD Million) 2024A-2034F
11.3.3.2.2.Market Share (%) 2024A-2034F
11.3.3.2.3.Y-o-Y Growth (%) 2024A-2034F
11.3.3.3. Hospital Pharmacies
11.3.3.3.1. By Value (USD Million) 2024A-2034F
11.3.3.3.2.Market Share (%) 2024A-2034F
11.3.3.3.3.Y-o-Y Growth (%) 2024A-2034F

12. North America Allergy Eye Drop Market Size & Forecast 2024A-2034F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Drug Class
12.3.2.By Type
12.3.3.By Distribution Channel
12.4. Country
12.4.1. United States
12.4.2.Canada

13. Europe Allergy Eye Drop Market Size & Forecast 2024A-2034F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Drug Class
13.3.2.By Type
13.3.3.By Distribution Channel
13.4. Country
13.4.1.Germany
13.4.2.United Kingdom
13.4.3.France
13.4.4. Italy
13.4.5.Spain
13.4.6.Russia
13.4.7.Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)

14. Asia-Pacific Allergy Eye Drop Market Size & Forecast 2024A-2034F
14.1.Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Drug Class
14.3.2.By Type
14.3.3.By Distribution Channel
14.4.Country
14.4.1.India
14.4.2.China
14.4.3. South Korea
14.4.4. Japan
14.4.5. Rest of APAC

15. Middle East and Africa Allergy Eye Drop Market Size & Forecast 2024A-2034F
15.1.Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Drug Class
15.3.2.By Type
15.3.3.By Distribution Channel
15.4. Country
15.4.1.Israel
15.4.2.GCC
15.4.3.North Africa
15.4.4. South Africa
15.4.5.Rest of Middle East and Africa

16. Latin America Allergy Eye Drop Market Size & Forecast 2024A-2034F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Drug Class
16.3.2.By Type
16.3.3.By Distribution Channel
16.4. Country
16.4.1.Mexico
16.4.2.Brazil
16.4.3.Rest of Latin America

17. Competitive Landscape
17.1. Company market share, 2023
17.2.Key player overview
17.3. Key stakeholders

18. Company Profiles
18.1.Allergan
18.1.1.Company Overview
18.1.2.Financial Overview
18.1.3.Key Product; Analysis
18.1.4.Company Assessment
18.1.4.1. Product Portfolio
18.1.4.2.Key Clients
18.1.4.3.Market Share
18.1.4.4.Recent News & Development (Last 3 Yrs.)
18.2.Similasan Corporation
18.3.Prestige Consumer Healthcare Inc.
18.4. Bausch & Lomb
18.5.Akorn, Inc.
18.6.Rohto Pharmaceutical Co., Ltd.
18.7.Novartis AG (Alcon)
18.8. Johnson & Johnson Vision
18.9.Sun Pharmaceutical Industries Ltd.
18.10.Santen Pharmaceutical Co., Ltd.
18.11. Eyevance Pharmaceuticals LLC
18.12. Scope Ophthalmics Ltd.
18.13. Pfizer Inc.
18.14.Apotex Inc
18.15. Optrex
18.16.Other Prominent Players

19. Appendix
20.Consultant Recommendation